Surveys

Everyone wants to know what happens next as the FDA deliberates what, if any, guidance it should draft regarding the regulation of Rx drug and device promotion on the Internet and social media.

Please take 2 minutes to answer a few short questions relating to the PhRMA's revised (as of July 10, 2008) PhRMA's New Code on Interactions with Health Professionals.

What impact will issues like drug reimporation, weak pipelines, decreasing profits, drug recalls, class action lawsuits, government regulation, etc., have on the course of the pharmaceutical industry in 2005?

What are the hot issues for pharma in 2004?

This survey asked respondents to comment on Johnson & Johnson's a new approach to TV and print campaigns that deals head-on with safety, putting drug risks on more-equal footing with drug benefits.

The Pharma Marketing Network 2006 Pharma Trend Survey asked respondents how likely or unlikely were a number of possible pharmaceutical industry trends to unfold in 2006.

This survey is sponsored by Pulse Media Response, which enables Pharmaceutical companies to increase their advertising ROI and the adoption of their compliance and retention programs by adding mobile communication capabilities to their patient communications and advertising.

You must get out there and network if you expect to keep your job, keep your current clients, find new new clients, and generally CREATE opportunities rather than wait for them to come to you! That is why Pharma Marketing Network is AGAIN hosting a networking event for pharmaceutical marketing professionals.

thinking about how permission-based marketing can be applied in the pharmaceutical industry.

Please take a few minutes to tell us who you think President-elect Obama should nominate as the new FDA Commissioner after he is sworn in as president. We've assembled a list of 10 contenders that have been suggested in blogs and other news sources.